NOVO NORDISK A/SNOVO NORDISK A/SNOVO NORDISK A/S

NOVO NORDISK A/S

No trades
See on Supercharts
Market capitalization
‪527.90 B‬EUR
‪11.22 B‬EUR
‪31.15 B‬EUR
‪3.15 B‬
Beta (1Y)
1.49

About NOVO NORDISK A/S

CEO
Lars Fruergaard Jørgensen
Headquarters
Bagsværd
Employees (FY)
‪63.37 K‬
Founded
1931
ISIN
DK0062498333
FIGI
BBG000DYN996
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of NOV is 118.16 EUR — it has increased by 0.99% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on XETR exchange NOVO NORDISK A/S stocks are traded under the ticker NOV.
NOVO NORDISK A/S is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for NOVO NORDISK A/S has a max estimate of 152.10 EUR and a min estimate of 70.98 EUR.
NOV earnings for the last quarter are 0.67 EUR whereas the estimation was 0.64 EUR which accounts for 4.02% surprise. Estimated earnings for the next quarter are 0.61 EUR. See more details about NOVO NORDISK A/S earnings.
NOVO NORDISK A/S revenue for the last quarter amounts to ‪7.86 B‬ EUR despite the estimated figure of ‪7.73 B‬ EUR. In the next quarter revenue is expected to reach ‪8.40 B‬ EUR.
Yes, you can track NOVO NORDISK A/S financials in yearly and quarterly reports right on TradingView.
Like other stocks, NOV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NOVO NORDISK A/S stock right from TradingView charts — choose your broker and connect to your account.
NOV reached its all-time high on Mar 7, 2024 with the price of 125.72 EUR, and its all-time low was 13.20 EUR and was reached on Jan 30, 2014.
See other stocks reaching their highest and lowest prices.
As of Apr 15, 2024, the company has ‪63.37 K‬ employees. See our rating of the largest employees — is NOVO NORDISK A/S on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NOVO NORDISK A/S EBITDA is ‪15.00 B‬ EUR, and current EBITDA margin is 47.96%. See more stats in NOVO NORDISK A/S financial statements.